Unusual Call Option Trade in Arcus Biosciences Worth ... - Nasdaq
| FBIOX Fund | USD 20.50 0.29 1.39% |
Slightly above 62% of Biotechnology Portfolio's investor base is looking to short. The analysis of overall sentiment of trading Biotechnology Portfolio Biotechnology mutual fund suggests that many investors are alarmed at this time. Biotechnology Portfolio's investing sentiment can be driven by a variety of factors including economic data, Biotechnology Portfolio's earnings reports, geopolitical events, and overall market trends.
Biotechnology |
Unusual Call Option Trade in Arcus Biosciences Worth ... Nasdaq
Read at news.google.com
 |
Biotechnology Portfolio Fundamental Analysis
We analyze Biotechnology Portfolio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotechnology Portfolio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotechnology Portfolio based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Biotechnology Portfolio is currently under evaluation in price to book among similar funds. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Biotechnology Portfolio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biotechnology Portfolio mutual fund to make a market-neutral strategy. Peer analysis of Biotechnology Portfolio could also be used in its relative valuation, which is a method of valuing Biotechnology Portfolio by comparing valuation metrics with similar companies.
Peers
Biotechnology Portfolio Related Equities
| FBSOX | It Services | 0.66 | ||||
| FSCSX | Software And | 0.16 | ||||
| FSPHX | Health Care | 0.19 | ||||
| FSELX | Fidelity Select | 0.20 | ||||
| FSPTX | Technology Portfolio | 0.33 |
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Portfolio financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Portfolio security.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |